Difference between revisions of "Phosphatase Subfamily ACP2"

From PhosphataseWiki
Jump to: navigation, search
(→‎Functions)
(→‎Domain Structure)
 
(31 intermediate revisions by 2 users not shown)
Line 1: Line 1:
−
[[Phosphatase classification|Phosphatase Classification]]: [[Phosphatase_Fold_HP|Fold HP]]: [[Phosphatase_Superfamily_HP|Superfamily HP]] (histidine phosphatase): [[Phosphatase_Family_HP2|Family HP, branch 2]]: [[Phosphatase_Subfamily_ACP2|Subfamily ACP2]]
+
__NOTOC__
 +
[[Phosphatase classification|Phosphatase Classification]]: [[Phosphatase_Fold_HP|Fold HP]]: [[Phosphatase_Superfamily_HP|Superfamily HP]]: [[Phosphatase_Family_HP2|Family HP, branch 2]]: [[Phosphatase_Subfamily_ACP2|Subfamily ACP2]]
 +
 
 +
ACP2 is a phosphatase subfamily that is found in most eukaryotes. Human has three copies with different tissue specificity.
  
 
=== Evolution ===
 
=== Evolution ===
−
ACP2 is found in [[Phosphatase_Glossary#holozoa|holozoa]], amoebozoa and some protists, but is absent from some fungi and most plants. There are usually multiple copies per genome. For example, human and fruit fly have 3 and 5 copies, respectively.
+
ACP2 is found in [[Phosphatase_Glossary#holozoa|holozoa]], amoebozoa and some protists, but is absent from some fungi and most plants. Amoebozoan ACP2s are quite divergent from holozoan ACP2s in sequence. There are usually multiple copies per genome. Human, Drosophila, and C elegans have 3, 5 and 21 copies, respectively.  
  
−
=== Domain ===
+
=== Domain Structure ===
−
ACP2 has either transmembrane region or signal peptide cleavage site at N terminus.
+
ACP2 has a phosphatase domain and an N-terminal hydrophobic region that in some genes is classified as a signal peptide, in other genes as a transmembrane region. Vertebrate ACP2 gene has a C-terminal YRHV motif that is necessary and sufficient to mediate recycling between endosome and lysosome <cite>Obermuller02</cite>.
 +
 
 +
=== Posttranslational modification ===
 +
Human ACPP, prostatic acid phosphatase, is glycosylated at three asparagine residues (N62, N188, N301) and has potent antinociceptive effects when administered to mice <cite>hurt12</cite>.
  
 
=== Functions ===
 
=== Functions ===
−
[http://www.ncbi.nlm.nih.gov/gene/55 Human ACPP] (acid phosphatase, prostate) is a prostate epithelium-specific differentiation antigen, and is decreased in prostate carcinomas. It has been show to downregulate prostate cell growth by dephosphorylating phosphotyrosine on c-ErbB-2, an oncoprotein in prostate cells <cite>ACPP_2</cite>. His-12 and Asp-258 of ACPP, but not Cys-183 or Cys-281, are required for the phosphatase activity <cite>ACPP_1</cite>.
+
[http://www.ncbi.nlm.nih.gov/gene/55 Human ACPP] (acid phosphatase, prostate) is a prostate epithelium-specific differentiation antigen (see [http://www.gtexportal.org/home/gene/ACPP GTEx]), and its expression is decreased in prostate carcinomas. It has been shown to downregulate prostate cell growth by dephosphorylating phosphotyrosine on the oncoprotein ErbB2 <cite>ACPP_2, chuang10</cite>. His-12 and Asp-258 of ACPP, but not Cys-183 or Cys-281, are required for the phosphatase activity <cite>ACPP_1</cite>. ACPP transcript is to be prostate specific  [http://www.gtexportal.org/home/gene/ACPP GTEx], though one paper reports that one of its isoforms is found in a broad of tissues <cite>Quintero07</cite>.
 +
 
 +
[http://www.ncbi.nlm.nih.gov/gene/93650 Human ACPT] (acid phosphatase, testicular) can act as a tyrosine phosphatase to modulate signals mediated by ErbB4 that are important for neuronal development and synaptic plasticity. ACPT and ErbB4 are both expressed in the brain where they are enriched at post-synaptic sites. ACPT can inhibit basal and neuregulin-induced tyrosine phosphorylation of ErbB4. ACPT-dependent dephosphorylation can regulate the proteolytic cleavage of ErbB4, and this process can be reversed with the tyrosine phosphatase inhibitor, pervanadate <cite>fleisig04</cite>. Curiously, ACPT transcript appears to be expressed almost exclusively in testis (<cite>yousef01</cite> and [http://www.gtexportal.org/home/gene/ACPT GTEx]).
  
−
[http://www.ncbi.nlm.nih.gov/gene/93650 Human ACPT] (acid phosphatase, testicular) can act as a tyrosine phosphatase to modulate signals mediated by ErbB4 that are important for neuronal development and synaptic plasticity. ACPT and ErbB4 are both expressed in the brain where they are enriched at post-synaptic sites. ACPT can inhibit basal and neuregulin-induced tyrosine phosphorylation of ErbB4. ACPT-dependent dephosphorylation can regulate the proteolytic cleavage of ErbB4, and this process can be reversed by applying the tyrosine phosphatase inhibitor, pervanadate <cite>fleisig04</cite>. It is worthy pointing out ACPT is specifically expressed in testis rather than brain (see [http://www.gtexportal.org/home/gene/ACPT GTEx]).
+
[http://www.ncbi.nlm.nih.gov/gene/53 Human ACP2] (acid phosphatase2, lysosomal) removes phosphate from protein residues that have been modified with mannose-6-phosphate (M6P) on their arrival at the lysosome. M6P is a trafficking recognition signal to direct proteins to the lysosome. This activity is also carried out by [[Phosphatase_Subfamily_ACP5|ACP5]], from the PPPL fold <cite>Makrypidi</cite>. It is not known to have protein substrates. Mouse ACP2 has a dynamic expression pattern in the brain and neural-specific phenotypes as well as bone deformation and kidney storage defects. The human gene is broadly expressed ([http://www.gtexportal.org/home/gene/ACP2 GTEx]).
  
 
===References===
 
===References===
 
<biblio>
 
<biblio>
 +
#Obermuller02 pmid=11801736
 +
#hurt12 pmid=22389722
 
#ACPP_1 pmid=11067847
 
#ACPP_1 pmid=11067847
 
#ACPP_2 pmid=9705354
 
#ACPP_2 pmid=9705354
 +
#fleisig04 pmid=15219672
 +
#Makrypidi pmid=22158965
 +
#yousef01 pmid=11414767
 +
#chuang10 pmid=20498373
 +
#Quintero07 pmid=17638863
 
</biblio>
 
</biblio>

Latest revision as of 03:13, 3 April 2017

Phosphatase Classification: Fold HP: Superfamily HP: Family HP, branch 2: Subfamily ACP2

ACP2 is a phosphatase subfamily that is found in most eukaryotes. Human has three copies with different tissue specificity.

Evolution

ACP2 is found in holozoa, amoebozoa and some protists, but is absent from some fungi and most plants. Amoebozoan ACP2s are quite divergent from holozoan ACP2s in sequence. There are usually multiple copies per genome. Human, Drosophila, and C elegans have 3, 5 and 21 copies, respectively.

Domain Structure

ACP2 has a phosphatase domain and an N-terminal hydrophobic region that in some genes is classified as a signal peptide, in other genes as a transmembrane region. Vertebrate ACP2 gene has a C-terminal YRHV motif that is necessary and sufficient to mediate recycling between endosome and lysosome [1].

Posttranslational modification

Human ACPP, prostatic acid phosphatase, is glycosylated at three asparagine residues (N62, N188, N301) and has potent antinociceptive effects when administered to mice [2].

Functions

Human ACPP (acid phosphatase, prostate) is a prostate epithelium-specific differentiation antigen (see GTEx), and its expression is decreased in prostate carcinomas. It has been shown to downregulate prostate cell growth by dephosphorylating phosphotyrosine on the oncoprotein ErbB2 [3, 4]. His-12 and Asp-258 of ACPP, but not Cys-183 or Cys-281, are required for the phosphatase activity [5]. ACPP transcript is to be prostate specific GTEx, though one paper reports that one of its isoforms is found in a broad of tissues [6].

Human ACPT (acid phosphatase, testicular) can act as a tyrosine phosphatase to modulate signals mediated by ErbB4 that are important for neuronal development and synaptic plasticity. ACPT and ErbB4 are both expressed in the brain where they are enriched at post-synaptic sites. ACPT can inhibit basal and neuregulin-induced tyrosine phosphorylation of ErbB4. ACPT-dependent dephosphorylation can regulate the proteolytic cleavage of ErbB4, and this process can be reversed with the tyrosine phosphatase inhibitor, pervanadate [7]. Curiously, ACPT transcript appears to be expressed almost exclusively in testis ([8] and GTEx).

Human ACP2 (acid phosphatase2, lysosomal) removes phosphate from protein residues that have been modified with mannose-6-phosphate (M6P) on their arrival at the lysosome. M6P is a trafficking recognition signal to direct proteins to the lysosome. This activity is also carried out by ACP5, from the PPPL fold [9]. It is not known to have protein substrates. Mouse ACP2 has a dynamic expression pattern in the brain and neural-specific phenotypes as well as bone deformation and kidney storage defects. The human gene is broadly expressed (GTEx).

References

  1. Obermüller S, Kiecke C, von Figura K, and Höning S. The tyrosine motifs of Lamp 1 and LAP determine their direct and indirect targetting to lysosomes. J Cell Sci. 2002 Jan 1;115(Pt 1):185-94. DOI:10.1242/jcs.115.1.185 | PubMed ID:11801736 | HubMed [Obermuller02]
  2. Hurt JK, Fitzpatrick BJ, Norris-Drouin J, and Zylka MJ. Secretion and N-linked glycosylation are required for prostatic acid phosphatase catalytic and antinociceptive activity. PLoS One. 2012;7(2):e32741. DOI:10.1371/journal.pone.0032741 | PubMed ID:22389722 | HubMed [hurt12]
  3. Meng TC and Lin MF. Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells. J Biol Chem. 1998 Aug 21;273(34):22096-104. DOI:10.1074/jbc.273.34.22096 | PubMed ID:9705354 | HubMed [ACPP_2]
  4. Chuang TD, Chen SJ, Lin FF, Veeramani S, Kumar S, Batra SK, Tu Y, and Lin MF. Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth. J Biol Chem. 2010 Jul 30;285(31):23598-606. DOI:10.1074/jbc.M109.098301 | PubMed ID:20498373 | HubMed [chuang10]
  5. Zhang XQ, Lee MS, Zelivianski S, and Lin MF. Characterization of a prostate-specific tyrosine phosphatase by mutagenesis and expression in human prostate cancer cells. J Biol Chem. 2001 Jan 26;276(4):2544-50. DOI:10.1074/jbc.M006661200 | PubMed ID:11067847 | HubMed [ACPP_1]
  6. Quintero IB, Araujo CL, Pulkka AE, Wirkkala RS, Herrala AM, Eskelinen EL, Jokitalo E, Hellström PA, Tuominen HJ, Hirvikoski PP, and Vihko PT. Prostatic acid phosphatase is not a prostate specific target. Cancer Res. 2007 Jul 15;67(14):6549-54. DOI:10.1158/0008-5472.CAN-07-1651 | PubMed ID:17638863 | HubMed [Quintero07]
  7. Fleisig H, El-Din El-Husseini A, and Vincent SR. Regulation of ErbB4 phosphorylation and cleavage by a novel histidine acid phosphatase. Neuroscience. 2004;127(1):91-100. DOI:10.1016/j.neuroscience.2004.04.060 | PubMed ID:15219672 | HubMed [fleisig04]
  8. Yousef GM, Diamandis M, Jung K, and Diamandis EP. Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis. Genomics. 2001 Jun 15;74(3):385-95. DOI:10.1006/geno.2001.6556 | PubMed ID:11414767 | HubMed [yousef01]
  9. Makrypidi G, Damme M, Müller-Loennies S, Trusch M, Schmidt B, Schlüter H, Heeren J, Lübke T, Saftig P, and Braulke T. Mannose 6 dephosphorylation of lysosomal proteins mediated by acid phosphatases Acp2 and Acp5. Mol Cell Biol. 2012 Feb;32(4):774-82. DOI:10.1128/MCB.06195-11 | PubMed ID:22158965 | HubMed [Makrypidi]
All Medline abstracts: PubMed | HubMed
Retrieved from "http://phosphatome.net/wiki/index.php?title=Phosphatase_Subfamily_ACP2&oldid=4140"